28. 全身性アミロイドーシス Systemic amyloidosis Clinical trials / Disease details

臨床試験数 : 261 / 薬物数 : 276 - (DrugBank : 81) / 標的遺伝子数 : 68 - 標的パスウェイ数 : 178

4 trials found

diseases per page:

Showing 1 to 4 of 4 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04847453 (ClinicalTrials.gov)	September 14, 2021	15/4/2021	Venetoclax, MLN9708 (IxazomibCitrate) and Dexamethasone for the Treatment of Relapsed or Refractory ...	A Phase 1/1a Study of Venetoclax, MLN9708 (IxazomibCitrate) and Dexamethasone for Relapsed/Refractor ...	Recurrent AL Amyloidosis;Refractory AL Amyloidosis	Procedure: Bone Marrow Aspiration and Biopsy;Drug: Dexamethasone;Drug: Ixazomib Citrate;Drug: Venetoc ...	National Cancer Institute (NCI)	NULL	Recruiting	18 Years	N/A	All	6	Phase 1	United States
2	NCT03618537 (ClinicalTrials.gov)	August 2, 2018	2/8/2018	Ixazomib Maintenance Study in Patients With AL Amyloidosis	IxazomibMaintenance Following Initial Therapy in Patients With Immunoglobulin Light Chain (AL) Amylo ...	AL Amyloidosis	Drug: Ixazomib;Drug: Dexamethasone	Memorial Sloan Kettering Cancer Center	Tufts Medical Center;Vanderbilt University Medical Center	Recruiting	18 Years	N/A	All	47	Phase 2	United States
3	NCT03283917 (ClinicalTrials.gov)	February 7, 2018	13/9/2017	Daratumumab, Ixazomib, and Dexamethasone in AL Amyloidosis	A Safety Study of Daratumumab, Ixazomib, and Dexamethasone in AL Amyloidosis	Newly Diagnosed Primary Amyloidosis;Recurrent Primary Amyloidosis;Refractory Primary Amyloidosis	Biological: Daratumumab;Drug: Dexamethasone;Drug: Ixazomib	M.D. Anderson Cancer Center	Janssen Pharmaceuticals;Takeda Pharmaceutical	Recruiting	18 Years	N/A	All	20	Phase 1	United States
4	NCT03236792 (ClinicalTrials.gov)	June 12, 2017	20/7/2017	Ixazomib In Combination With Cyclophosphamide And Dexamethasone for Newly Diagnosed AL Amyloidosis	Phase 1/2 Study Of IxazomibIn Combination With Cyclophosphamide And Dexamethasone In Patients With N ...	AL Amyloidosis	Drug: Ixazomib;Drug: Cyclophosphamide;Drug: Dexamethasone	Icahn School of Medicine at Mount Sinai	Millennium Pharmaceuticals, Inc.	Recruiting	18 Years	N/A	All	30	Phase 1/Phase 2	United States

First Previous1Next Last